1.Nosocomial Infections in Children′s Hospital:A Long Term Study
Danyang ZHAO ; Baolan ZOU ; Tongjie HE
Chinese Journal of Nosocomiology 2004;0(10):-
OBJECTIVE To describe the epidemiology of nosocomial infections in children′s hospital.METHODS We performed a prospective and retrospective analysis to determine the prevalence of nosocomial infection.Data were collected from 2000 to 2007 in hospitalized cases.RESULTS The incidence of nosocomial infections was 3.43%,from then 40.27% were upper respiratory infections,28.94% of gastrointestinal infections,and 17.61%% bronchitis and pneumonia.The incidence had a tendency decreaseing P
2.Case-control Study on Economic Impact of Nosocomial Rotavirus Infection in Children′s Hospital
Danyang ZHAO ; Baolan ZOU ; Xiongmin CHEN ; Shaolan FU
Chinese Journal of Nosocomiology 2009;0(18):-
OBJECTIVE To determine the extra-lengh of stay and the economic loss for nosocomial infections of group A rotavirus in children′s hospital. METHODS We performed a 1∶1 case-control study to determine the cost of nosocomial rotavirus infection. Data of hospitalized cases were collected from Jan 1 2007 to Dec 31 2007. RESULTS The average medical expenses in case and control group were 7589 yuan and 5319 yuan,the average increased cost per case was 2269 yuan,the expenses for medicine,treatment,laboratory test and bed accounted for 47.42%,19.96%,17.10% and 9.03%,respectively (P
3.Live biotherapeutic products: the forefront of innovative drug development driven by biotechnology.
Danyang ZOU ; Yumeng DONG ; Jingyu CHEN
Chinese Journal of Biotechnology 2023;39(4):1275-1289
As human microbiome research advances, a large body of evidence shows that microorganisms are closely related to human health. Probiotics were discovered and used as foods or dietary supplements with health benefits in the last century. Microorganisms have shown broader application prospects in human health since the turn of the century, owing to the rapid development of technologies such as microbiome analysis, DNA synthesis and sequencing, and gene editing. In recent years, the concept of "next-generation probiotics" has been proposed as new drugs, and microorganisms are considered as "live biotherapeutic products (LBP)". In a nutshell, LBP is a living bacterial drug that can be used to prevent or treat certain human diseases and indications. Because of its distinct advantages, LBP has risen to the forefront of drug development research and has very broad development prospects. This review introduces the varieties and research advances on LBP from a biotechnology standpoint, followed by summarizing the challenges and opportunities for LBP clinical implementations, with the aim to facilitate LBP development.
Humans
;
Probiotics
;
Dietary Supplements
;
Bacteria
;
Drug Development
;
Biotechnology
4.Influencing factors and nomogram prediction model of pregnancy outcome of patients with vaginal bleeding after IVF/ICSI-ET
Damin Zhu ; Huijuan Zou ; Jing Wang ; Cong Ma ; Xiaoqing Peng ; Danyang Li ; Yangfan Zhou ; Yulu Yang ; Yunxia Cao ; Xiaofeng Xu
Acta Universitatis Medicinalis Anhui 2022;57(7):1171-1176
Objective:
To investigate the risk factors affecting the occurrence of complications in patients with vaginal bleeding after in vitro fertilization/intracytoplasmic sperm injection embryo transfer(IVF/ICSI-ET) and the construction of nomogram prediction model.
Methods:
A total of 272 patients with threatened abortion after IVF/ICSI-ET were retrospectively analyzed in this study. They were divided into the live birth group and abortion group according to the final outcome of pregnancy. Patient characteristics were evaluated using the chi-square test, independent-samples Student's t-test or Wilcoxon rank sum test. A nomogram was created to predict the pregnancy outcome of women with threatened abortion who received IVF/ICSI using multivariate logistic regression coefficients.
Results:
There was no significant difference in the basic data, percentage of frozen embryos, treatment method, number of embryos transferred, high-quality embryo rate, and embryo implantation rate of the live birth group and abortion group(P>0.05). There were significant differences in body mass index, the onset of vaginal bleeding time after transplantation, serum levels of hCG and progesterone on 14 th day after embryo-transfer, and the number of gestational sacs between the two groups(P<0.05). After multivariate logistic regression analysis, the onset of vaginal bleeding time after transplantation and serum hCG levels on 14 th day after transfer were statistically significant(P<0.05). The nomogram was established based on the above indicators, with an area under the curve of 0.710 for the nomogram. The area under the ROC curve of our nomogram was better than the area under the ROC curve of a single risk factor(AUC of bleeding time after embryo-transfer: 0.644, AUC of serum hCG14:0.625).
Conclusion
The nomogram model established based on the onset of vaginal bleeding time after embryo-transfer and serum hCG value on 14 th day after embryo-transfer can better predict pregnancy outcome of patients with threatened abortion after IVF/ICSI-ET.